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Abstract
Excluding pregnancy in individuals prior to initiating contraception is important. The
Pregnancy Reasonably Excluded Guide (PREG) uses twelve questions related to a patient’s
reproductive history to effectively rule out pregnancy without administering a urine pregnancy
screen, saving the patient both time and money. The PREG survey was given at Mayo Clinic in
Rochester, MN, from 2015 to 2018 to all patients receiving an Intrauterine Device or Subdermal
Implant.
This study examined data from the 2018 collection year to determine if urine screening
requests by providers were reduced from the pre-PREG data. It also determined whether urine
tests were requested disproportionally for patients by their age range or type of contraceptive
procedure. One-hundred sixty-eight women between the ages of 18 and 50 were included, with
the majority identifying as white (84%) between the ages of 18 and 31 (54%).
Using a Chi-square analysis, it was found that neither urine test by age (p=0.69) nor
urine test by procedure (p=0.98) were significant. Urine tests were not requested more often
for certain procedures or by patient age. However, the number of urine screens requested prePREG compared to the number requested post-PREG for the year 2018 was significant (P<0.01).
Through implementation of the PREG survey, urine pregnancy testing was drastically
reduced and in turn, there were reduced costs to patients and the clinics.

2

Introduction
Unplanned pregnancy is defined by the CDC as a pregnancy that is unwanted or
mistimed (2015), and in the United States, approximately 50% of pregnancies are unplanned
(Winner, et al., 2012). According to Gibson, Koenig, & Hindin (2008), there are a handful of ill
effects that stem from an unplanned pregnancy for both the child and the parents. These
include higher risk behaviors in mothers like continuing to smoke, drink alcohol, or use illegal
drugs after a pregnancy is confirmed. In one study, women with unintended pregnancies were
26% less likely to quit smoking, more likely to postpone prenatal care, and less likely to
breastfeed or breastfeed for less than the recommended time (Gibson, et al., 2012). Effects to
mothers include an increase in depression, unsafe abortion, and maternal death (Gibson, et al.,
2012).
Some of the most effective contraceptive methods to prevent these negative outcomes
are Long-Active Reversible Contraceptives or LARC methods. The category includes intrauterine
devices like Mirena and Paragard, and subdermal implants like Nexplanon. While these
methods are extremely effective, failing less than 1% of the time, only 6% of women on
hormonal contraception were using these methods in 2012 (Winner, et al., 2012).
There are a few possible barriers to choosing LARC methods. The first is a lack of
comfort inserting the devices among primary care providers, who are often the main providers
of women’s health care. One study found that 87% of respondents were not trained to place
subdermal implants and 41% were not trained to place IUDs (Lunde, et al., 2014). Having
providers who are trained in LARC method insertion is the strongest predictor of their patients’
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use of the method, as those who lack training are less likely to recommend the method.
Greenberg, et al., 2012).
Once patients have decided that a LARC method is right for them, there are a few
barriers that stand between them and the actual procedure. One is that providers should be
“reasonably certain” that patients are not already pregnant before beginning a new
contraceptive method, due in part to the redundancy of starting the method and the belief of
some providers that contraceptives can cause harm to an early pregnancy (Morroni, Findley,
Westhoff, 2017). Two accepted ways to determine pregnancy status are by administering a
pregnancy test, or by having the patient complete the procedure during their menses. These
requirements can prove difficult to women who have difficulty traveling to appointments, need
time off work, or need to be on a birth control method as soon as possible. In addition, luteal
phase pregnancies may not be detected by a urine test or indicated by a lack of active bleeding.
A common problem, however, is that women experience delays when waiting for urine
pregnancy test results, or may not be able to accurately take a urine pregnancy test. Morroni et
al. found that women were less likely to return for a second appointment and women who did
return were 60% more likely to have gotten pregnant in the meantime (2017).
A method that deserves exploration is the use of a pregnancy exclusion checklist.
Implementing a checklist would allow providers to forgo a urine screen by reasonably excluding
pregnancy based on a survey with questions related to menstrual cycle, sexual history, and
prior contraceptive use. Min, Buckel, Secura, Peipert, and Madden (2014) found that their sixquestion exclusion guide had an accuracy of ruling out luteal pregnancy in 99% of women who
also had a negative urine pregnancy test and ruled out typical pregnancy in 69% of women who
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had a negative pregnancy test. Another study looked at using a pregnancy exclusion checklist in
teenagers and younger women. Whiteman, et al. looked at a group of black females ages 14-19
and found their guide had a sensitivity range of 55%-100% and a specificity range of 39% to 89%
(2014). The range of results could be due to the irregularity that is typical of younger women’s
menstrual cycles.
Mayo Clinic in Rochester, Minnesota has developed their own version of a survey titled
“Pregnancy Reasonably Excluded Guide” or “PREG”. They implemented the 12-question patient
survey in 2015 and, when appropriate, have been using it in place of traditional pregnancy tests
prior to gynecological procedures. Additional urine testing could still be requested at the
provider’s discretion after discussing the survey results with the patient and if concerns for
pregnancy were still present. This study aimed to examine whether the PREG survey effectively
reduced the number of urine tests performed from the pre-PREG data of 2015 to the post-PREG
data of 2018. It also looked at whether when additional urine testing was requested, if it was
done so more often for certain age groups or certain procedure types (intrauterine device vs
subdermal implant).
Methods
The PREG survey was given to all patients when they checked in as part of their pregynecology procedure appointment paperwork and health histories. (See appendix A for survey
questions and B for the scoring guide.) Only the surveys of those who had consented to
research at Mayo Clinic were included in the study with an original sample of 1,012 female
patients ages eighteen to fifty. The survey answers were entered into an excel sheet, with
additional chart review completed if necessary to clarify patients’ answers.
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For this post-PREG study, the number of requested urine screens from the 2018 collection
period (January through April) was compared with the pre-PREG sample from the 2015
collection period (January through September). There were a total of 185 patients ages
eighteen to fifty in the pre-PREG group and 168 patients ages eighteen to fifty in the post-PREG
group. Figure A below shows the age breakdown of the 168 patients and figure B shows the
racial representation present, both from post-PREG in 2018. Other demographic data from the
pre-PREG group was not available for comparison.

2018 Age Distribution

17%

18-30
31-40
54%
29%

41-50

Figure A: Age distribution of patients who took PREG in 2018
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2018 Race Distribution

2% 4%

3%
7%

African
Asian
Did Not Disclose
Other
84%

White

Figure B: Race distribution of patients who took PREG in 2018
The PREG survey (Appendix A) includes twelve questions including the following:
1. I am pregnant.
2. I’ve had a bilateral tubal ligation (“tubes tied,” Essure with confirmatory testing).
3. I’ve had a hysterectomy and/or bilateral salpingo-oophorectomy (both ovaries removed).
4. I am menopausal and greater than 45 years old- no period spontaneously for the past 12
months.
5. I have a current IUD (Mirena, Skyla, ParaGard, Liletta) in place.
6. I have a current contraceptive implant (Nexplanon, Implanon) in place.
7. I have not had sexual intercourse with a man since the start of my last normal period
8. My partner has had a vasectomy and he has had a negative post-surgery semen analysis.
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9. I started bleeding from a normal period within the last seven days.
10. I reliably use hormonal contraception (“the pill,” Depo Provera shots, patch, ring).
11. I think I may be pregnant or would like a pregnancy test.
12. None of these apply
To score the survey (see Appendix B for full scoring guide), the questions are divided
into three groups: A (Questions 1-6), B (Questions 7-10), and C (Questions 11 and 12). Women
who answered questions in Category A were deemed unlikely to be pregnant today or become
pregnant soon. They are physically unable to become pregnant or use a contraceptive method
that is free of human error and therefore more effective. Category B women were unlikely to
be pregnant today but would need additional evaluation if they were to need to come back in
the future. These women are less likely to be pregnant, but the questions rely more on the
patient’s report and the accuracy of their recall. The questions can also not rule out a luteal
pregnancy with question #9. Women answering from Category C could not rule out pregnancy
today and would need some type of pregnancy testing prior to their procedure and if it was
determined a pregnancy test would not be accurate due to recent sexual activity and menstrual
cycle, they would be asked to rescheduled and come back when they could complete the
pregnancy test and the results would be more accurate.
Data is summarized using counts and percentages. A chi square analysis was performed
to determine whether urine tests were requested more often pre-PREG compared to postPREG.
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A Chi-square analysis was also used to determine if urine tests were requested (a) more
often for either the subdermal implant or IUD or (b) more often for a certain age range or type
of contraceptive procedure. A p-value < 0.05 was considered statistically significant.
Results
Below, Table A shows the breakdown of answers given on the PREG survey in 2018.

Table A: Breakdown of 2018 PREG survey patient responses
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Only a small percentage (0.6%) had been requested to complete a urine test prior to
their appointment. Additional urine screens could have been requested after reviewing a
patient’s survey. The majority (56%) chose an option in Category B, which indicated they were
unlikely to be pregnant today, but would need additional evaluation in the future.
Of the 185 patients from pre-PREG in 2015, 98 (53%) were requested to have urine
screens. Figure E shows there was a statistically significant difference in the percentage of
urine screens ordered in 2015 compared to 2018 as shown in Figure C (53% vs. 16%. P<0.01).

Figure C: Comparison of requested urine screens requested pre- and post- PREG survey

Out of the 168 patients in 2018, the majority were white (84.52%) and between the
ages of 18 and 30 (54.17%). The mean age was to undergo a contraceptive procedure was 30
and most patients (55.35%) had never given birth. Demographic information for the pre-PREG
patients was not available for comparison. See Table B below for additional demographic
information.
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Table B: Demographic information for patients who took PREG in 2018
16% of patients (21 out of 131) who received an IUD had a urine test and 16% of
patients (6 out of 37) who received a subdermal had a urine test. There was no association
between type of protection and provider decision for a urine screening (p>0.05).
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Figure D below shows a breakdown of the urine test requests by IUD insertion or subdermal
implant

Figure D: Breakdown of urine screens requested by procedure type
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A second question to be determined by the data was whether urine tests were
requested more often for one age group compared to another. The distribution of urine tests
completed among the three age groups (18-30, 31-40, and 41-50) were similar to each other
(p>0.05) suggesting that a provider was no more likely to request patients of certain ages to
complete urine tests more often than patients in other age groups. Figure E shows a
breakdown of the age groups and requested urine tests and illustrates a similar distribution
among them.

Figure E: Breakdown of urine screens requested by age group
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Discussion
The main goal of the study was to determine if adding the survey helped to reduce the
number of urine screens requested by providers prior to procedures, indicated by few ordered
urine screens. Additional goals were to confirm if there were any biases towards a certain
procedure or age range in terms of requesting a urine screen. The percentage of urine screens
requested dropped significantly from the pre-PREG collection period (January to August 2015)
to the post-PREG collection period. It is possible that the percentage of urine screens dropped
more dramatically in this study because it compared only the most recent post-PREG data from
2018 to 2015 pre-PREG data. For example, comparing pre-PREG 2015 urine screen data to postPREG 2016 data likely shows a more modest drop in urine screen orders as providers were still
learning to use the survey and trust its recommendations.
The results of the analysis done on pre- and post- PREG survey answers support the
continued use of the survey in the primary care gynecology clinic. It provides a convenient way
for patients to reasonably exclude pregnancy without the extra cost of completing a urine test
or the inconvenience of scheduling an appointment during menses. No patients in the sample
had any complications such as device expulsion and no patients were actually pregnant when
the PREG survey indicated it was unlikely up through the end of data collection in late 2018.
In addition, being able to do same-day procedures opened provider accessibility
because patients did not need to use two appointment slots on different days. Because patients
are less likely to return for a second appointment (Morroni et al, 2017), patients should be set
up as soon as possible with their preferred method, preferably same-day to reduce chances of
pregnancy while waiting for a second appointment.
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The PREG survey has potential to be useful in areas other than gynecology and primary
care. Pregnancy testing is also done prior to surgeries and other kinds of procedures (Kahn, et
al., 2008) and it could be a useful tool to rule out pregnancy in those patients as well. Additional
research would need to be done to determine if there was a difference in how providers not
specialized in gynecology or primary care would evaluate the survey results, particularly for the
women in Category B, who are not pregnant today but may in the future. It’s possible these
providers would not be as confident in the survey and therefore still request urine tests. It
would be necessary to look at whether safety for patients was affected based on who is reading
the results.
Another area for additional study would be to look at the use of the PREG survey in
younger patients. Unintended pregnancy among teenagers is a current public health issue and
teenagers are more likely to stick with a contraceptive method that does not require extra
thought or effort the way oral contraceptives and condoms do. (Fleming, Sokoloff, & Raine,
2010). It would be important to look at the efficacy of the survey to exclude pregnancy and how
issues commonly affecting teenagers like menstrual irregularity would affect the results.
Limitations
Limitations of this study include having a small sample size to analyze. It’s also possible
that different providers were more (or less) conservative in their decisions to use the PREG
survey as the deciding factor for requesting urine screens. Another limitation was only using
data from patients aged 18-50. Data from patients older than 50 and younger than 18 were
included in the original data, but removed for this study. It is possible a bias in requesting urine
tests could exist for older or younger patients.
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Conclusion
LARC methods are the most effective types of birth control, removing the possibility of
human error. When pregnancies are unplanned, they can come with an array of negative
effects and behaviors that can affect a child for years to come. When a woman is ready to
initiate a contraceptive method, it’s important to be able to get it to her in a timely manner to
further reduce her chance of unplanned pregnancy. The PREG survey has been shown to have a
positive effect on patients by accurately and safely allowing them to have the procedures they
need without delay.
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